Carret Asset Management, LLC Abb Vie Inc. Transaction History

Carret Asset Management, LLC

$911 Million
Q2 2025

A detailed history of Carret Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Carret Asset Management, LLC holds 50,024 shares of ABBV stock, worth $9.82 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

50,024

Previous 50,742 1.42%

Holding current value

$9.82 Million

Previous $10.6 Million 12.66%

% of portfolio

1.02%

Previous 1.23%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$170.16 - $206.27 $122,174 - $148,101	-718 Reduced 1.42%	50,024 $9.29 Million
Q1 2025 Apr 22, 2025	BUY	$169.2 - $216.66 $38,070 - $48,748	225 Added 0.45%	50,742 $10.6 Million
Q4 2024 Feb 10, 2025	SELL	$164.99 - $203.87 $39,927 - $49,336	-242 Reduced 0.48%	50,517 $8.98 Million
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $165,642 - $201,522	-1,011 Reduced 1.95%	50,759 $10 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $28,636 - $33,440	-185 Reduced 0.36%	51,770 $8.88 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $62,489 - $71,201	-391 Reduced 0.75%	51,955 $9.46 Million
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $17,888 - $20,146	-130 Reduced 0.25%	52,346 $8.11 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $96,184 - $111,348	-720 Reduced 1.35%	52,476 $7.82 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $1.04 Million - $1.29 Million	-7,822 Reduced 12.82%	53,196 $7.17 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $615,315 - $708,627	-4,255 Reduced 6.52%	61,018 $9.72 Million
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $55,185 - $66,182	-399 Reduced 0.61%	65,273 $10.5 Million
Q3 2022 Oct 11, 2022	SELL	$134.21 - $153.93 $130,854 - $150,081	-975 Reduced 1.46%	65,672 $8.81 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $191,154 - $243,019	-1,389 Reduced 2.04%	66,647 $10.2 Million
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $10,294 - $12,772	-78 Reduced 0.11%	68,036 $11 Million
Q4 2021 Jan 10, 2022	BUY	$107.43 - $135.93 $15,040 - $19,030	140 Added 0.21%	68,114 $9.22 Million
Q3 2021 Oct 27, 2021	SELL	$106.4 - $120.78 $31,813 - $36,113	-299 Reduced 0.44%	67,974 $7.33 Million
Q2 2021 Jul 14, 2021	SELL	$105.21 - $117.21 $24,198 - $26,958	-230 Reduced 0.34%	68,273 $7.69 Million
Q1 2021 Jul 14, 2021	BUY	$102.3 - $112.62 $10,230 - $11,262	100 Added 0.15%	68,503 $7.41 Million
Q4 2020 Mar 16, 2021	SELL	$80.49 - $108.67 $18,110 - $24,450	-225 Reduced 0.33%	68,403 $7.33 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $225,256 - $264,376	-2,622 Reduced 3.68%	68,628 $6.01 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $216,881 - $290,220	2,956 Added 4.33%	71,250 $7 Million
Q1 2020 May 18, 2020	SELL	$64.5 - $97.79 $73,659 - $111,676	-1,142 Reduced 1.64%	68,294 $5.2 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $106,824 - $133,660	1,481 Added 2.18%	69,436 $6.15 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $6,612 - $7,950	-105 Reduced 0.15%	67,955 $5.15 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $16,425 - $20,995	250 Added 0.37%	68,060 $4.95 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $50,141 - $59,013	-650 Reduced 0.95%	67,810 $5.47 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $21,408 - $26,402	275 Added 0.4%	68,460 $6.31 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $76,996 - $85,595	-866 Reduced 1.25%	68,185 $6.45 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $61,050 - $72,236	-680 Reduced 0.98%	69,051 $6.4 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $302,068 - $404,498	-3,283 Reduced 4.5%	69,731 $6.6 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $29,107 - $31,918	-325 Reduced 0.44%	73,014 $7.06 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $32,480 - $41,487	465 Added 0.64%	73,339 $6.52 Million
Q2 2017 Aug 15, 2017	BUY	N/A	72,874	72,874 $5.28 Million

Others Institutions Holding ABBV

# of Institutions

4,252

Shares Held

1.27B

Call Options Held

16.5M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.

Account

Carret Asset Management, LLC Abb Vie Inc. Transaction History